Just Published

JCP
Pharmacotherapies for Co-Occurring Stimulant Use Disorder and ADHD
Meta-Analysis

August 31, 2026

Stimulant-based pharmacotherapies, particularly higher-dose methylphenidate and mixed amphetamine salts, were associated with superior outcomes for both stimulant-use indicators and ADHD symptoms.
, , , et al
JCP
Electroconvulsive Therapy and All-Cause, Nonsuicide, and Suicide Mortality
Clinical and Practical Psychopharmacology

August 31, 2026

Evidence on the association of ECT with lower risk of short- and long-term all-cause mortality, nonsuicide mortality, and suicide mortality is reviewed.
PCC
Managing 7-hydroxymitragynine Withdrawal
Case Report

August 27, 2026

A 49-year-old man taking “7-OH” experienced significant opioid withdrawal symptoms that resolved with high-dose buprenorphine-naloxone treatment.
,
JCP
Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment
Original Research

August 26, 2026

Stimulant and nonstimulant use during pregnancy were both associated with increased risk for obstetric complications vs no medication.
,
JCP
ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference
Commentary

August 26, 2026

Comments on a recent study by Babinski and Tuan finding ADHD medication use predictive of adverse pregnancy outcomes.
JCP
The Prescriber’s Guide to Oral Ketamine for Depression
Clinical and Practical Psychopharmacology

August 26, 2026

Explains clinical contexts in which oral ketamine can be used and presents a detailed protocol for the use of this intervention.

Explore
By Topic

View all topics
Addiction Anxiety Bipolar Disorder Depression (MDD) Movement Disorders Neurology Obsessive-Compulsive and Related Disorders Psychedelics Psychopharmacology Schizophrenia/Schizoaffective Disorders Tardive Dyskinesia

Recent Features

Neural network illustration exploring psychedelic therapy mechanisms
Portrait of Dr. David T. Liebers discussing metabolism in psychiatry
Promotional graphic shows Biostats Made Simple by Dr. Andrade, promoting mastering statistics for clinical decisions.
The Journal of Clinical Psychiatry logo with person reading research publication

Original Research

PCC
Anxiety, Depression, and Substance Use in Schizophrenia
Original Research

August 20, 2026

Early screening and management of anxiety and depressive symptoms in schizophrenia is crucial, as their presence significantly correlates with illness severity and may shape long-term functional outcomes.
, ,
JCP
Life’s Essential 8 Cardiovascular Health and Suicide Mortality
Original Research

August 19, 2026

Poor cardiovascular health status, as reflected by a low Life’s Essential 8 score, was associated with suicide mortality.
,
JCP
Persistent Gaps in Diversity of US Antidepressant Trials
Original Research

August 12, 2026

Reporting gaps and multiple underrepresented groups persist in US antidepressant trials, limiting generalizability.
, , , et al

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals. Now featuring The JCP Podcast: conversations with experts exploring the research shaping clinical care.  

EXPLORE JCP
JCP
From Screening to Treatment: Rethinking Suicide Risk with Elizabeth Ballard, PhD
Podcast

August 25, 2026

Dr. Elizabeth Ballard discusses suicide risk screening tools, ketamine’s rapid antisuicidal effects, sleep biomarkers, and ethics of suicide research.
,
JCP
Genetically Informed Triangulation Can Strengthen Counseling About Gestational Antidepressant Exposure
Letter to the Editor

August 19, 2026

The authors discuss a recent article by Chittaranjan Andrade.
, ,

Explore Special Sections from JCP

Focus on Childhood and Adolescent Mental Health Early Career Psychiatrists Focus on Geriatric Psychiatry Focus on Psychosis Focus on Psychotherapy Focus on Suicide Focus on Women’s Mental Health

The Primary Care Companion for CNS Disorders

The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.

View PCC Articles
PCC
Generative AI in Mental Health
Rounds in the General Hospital

August 25, 2026

As patients rely more on generative AI to assess and manage symptoms, they may mistake its output for professional advice and be unable to gauge accuracy, quality, or biases.
, , , et al
PCC
Aripiprazole-Induced Hiccups
Case Report

August 25, 2026

A 29-year-old man hospitalized for psychotic symptoms in the context of methamphetamine experienced persistent hiccups after starting aripiprazole.
, , , et al

ASCP - American Society of Clinical Psychopharmacology logo

Read articles from ASCP Corner

ASCP Corner

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe